| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.16T | 4.41T | 4.39T | 4.63T | 3.98T | 3.26T |
| Gross Profit | 1.21T | 1.28T | 1.15T | 1.24T | 1.11T | 926.25B |
| EBITDA | 439.97B | 205.68B | 561.06B | 456.72B | 542.84B | 283.92B |
| Net Income | 25.00B | 45.02B | 119.60B | 96.46B | 177.16B | -7.56B |
Balance Sheet | ||||||
| Total Assets | 5.84T | 5.89T | 6.10T | 5.77T | 5.57T | 5.29T |
| Cash, Cash Equivalents and Short-Term Investments | 288.47B | 392.25B | 377.73B | 297.22B | 245.79B | 349.58B |
| Total Debt | 2.08T | 2.04T | 2.20T | 2.24T | 2.16T | 2.35T |
| Total Liabilities | 3.56T | 3.61T | 3.83T | 3.79T | 3.73T | 3.72T |
| Stockholders Equity | 1.73T | 1.74T | 1.76T | 1.56T | 1.46T | 1.24T |
Cash Flow | ||||||
| Free Cash Flow | 247.40B | 238.31B | 190.67B | 74.19B | 89.21B | 210.12B |
| Operating Cash Flow | 539.19B | 552.85B | 465.15B | 355.19B | 346.87B | 467.13B |
| Investing Cash Flow | -230.69B | -275.43B | -246.09B | -247.63B | -128.78B | -217.01B |
| Financing Cash Flow | -268.06B | -246.65B | -241.72B | -60.78B | -336.28B | -142.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ¥718.66B | 15.79 | 20.91% | 3.32% | 13.93% | 23.19% | |
| ― | $706.90B | 14.65 | 6.04% | 4.54% | 3.71% | -19.97% | |
| ― | $1.08T | 29.38 | 5.90% | 1.09% | 1.60% | -6.74% | |
| ― | ¥1.67T | 13.98 | 6.55% | 3.22% | 5.91% | 78.43% | |
| ― | $747.17B | 76.93 | 0.92% | 2.61% | 0.98% | ― | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | $1.16T | 46.06 | 1.29% | 3.97% | -6.66% | -78.39% |
Mitsubishi Chemical Group Corporation has revised its financial forecast for the fiscal year ending March 31, 2026, predicting a decrease in core operating income by 5.7% to ¥250.0 billion. This revision is attributed to a reduction in price gaps and sales volume declines in the MMA & Derivatives and Basic Materials & Polymers segments, despite strong demand in the Specialty Materials segment. The company also anticipates lower operating and net income due to special item losses expected in the second half of fiscal 2025, alongside structural reforms.
The most recent analyst rating on (JP:4188) stock is a Hold with a Yen800.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.
Mitsubishi Chemical Group Corporation reported its consolidated financial results for the first half of the fiscal year ending March 31, 2026, showing a decline in sales revenue by 10.5% compared to the previous year. Despite this, the company experienced a significant increase in net income attributable to owners of the parent by 169.1%, primarily due to the reclassification of discontinued operations following the transfer of Mitsubishi Tanabe Pharma Corporation and its subsidiaries.
The most recent analyst rating on (JP:4188) stock is a Hold with a Yen800.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.
Mitsubishi Chemical Group Corporation announced amendments to its plan to cancel its own shares, initially resolved in May 2025. The company will now cancel 64,820,900 treasury shares on October 28, 2025, instead of the previously scheduled June 30, 2026. This move is part of a broader strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (JP:4188) stock is a Hold with a Yen851.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.
Mitsubishi Chemical Group Corporation has announced the implementation of a voluntary retirement program as part of its Medium-term Management Plan 2029. This initiative aims to optimize the organization’s operations and workforce, reduce fixed costs, and support employees in pursuing new career opportunities. The restructuring charges are expected to be approximately 30 billion yen, impacting the fiscal year ending March 2026, but no revisions to the forecast are currently planned.
The most recent analyst rating on (JP:4188) stock is a Hold with a Yen903.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.
Mitsubishi Chemical Group Corporation announced a change in its specified subsidiary status following the acquisition of Coregas Pty Ltd, an industrial gas company in Australia, through its subsidiary Nippon Sanso Holdings Corporation. This acquisition, completed on July 1, 2025, strengthens MCG’s position in the industrial gas market in Australia and New Zealand, potentially enhancing its operational capabilities and market reach in the region.
The most recent analyst rating on (JP:4188) stock is a Hold with a Yen903.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.
Mitsubishi Chemical Group Corporation announced the completion of an interim review of its Japanese consolidated financial results for the first quarter of the fiscal year ending March 31, 2026, by an independent auditor, confirming no changes to the previously disclosed statements. The company reported a decline in sales revenue and net income compared to the previous year, reflecting challenging market conditions. The financial results highlight the company’s ongoing efforts to manage its operations effectively amidst a dynamic economic environment.
The most recent analyst rating on (JP:4188) stock is a Buy with a Yen1000.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.
Mitsubishi Chemical Group Corporation has completed the acquisition of 889,200 treasury shares valued at JPY 720,259,790, as part of a resolution made by its Board of Directors. This acquisition is part of a larger plan to purchase up to 100 million shares, reflecting the company’s strategic financial management and potential impact on shareholder value.
The most recent analyst rating on (JP:4188) stock is a Buy with a Yen1000.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.
Mitsubishi Chemical Holdings Corporation is a diversified chemical company operating in the specialty materials, industrial gases, and basic materials sectors, known for its global presence and innovative solutions in the chemical industry.
Mitsubishi Chemical Group reported a decline in its financial performance for the first quarter of the fiscal year ending March 31, 2026, with significant decreases in sales revenue and net income compared to the previous year. The company attributes part of this decline to the reclassification of its subsidiary, Mitsubishi Tanabe Pharma Corporation, as discontinued operations, impacting its consolidated financial results.
The most recent analyst rating on (JP:4188) stock is a Buy with a Yen1000.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.
Mitsubishi Chemical Group Corporation announced the acquisition of 28,715,600 of its common shares, valued at JPY 22,725,462,410, during July 2025. This move is part of a broader plan approved by the Board of Directors to acquire up to 100 million shares by May 2026, with a maximum budget of JPY 50 billion. The acquisition aims to enhance shareholder value and optimize the company’s capital structure.
The most recent analyst rating on (JP:4188) stock is a Buy with a Yen1040.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.